CENTER FOR CANCER SIGNALING NETWORKS

癌症信号网络中心

基本信息

  • 批准号:
    6988679
  • 负责人:
  • 金额:
    $ 181.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is proposed to establish a COBRE comprised of 5 research projects headed by junior and early career faculty and 3 research core facilities. The scientific theme of the Center will be cancer signaling networks, namely, the molecular mechanisms by which signaling networks relevant to carcinogenesis are regulated: transcription, protein phosphorylation and protein degradation. Some of the focal points of the proposed research will be DNA repair, Wnt and IGF-1 signaling, proteome-wide analysis of protein phosphorylation, ubiquitin-mediated proteolysis, global RNA polymerase II machinery, transgenic mouse models of carcinogenesis, and bioinformatic inference of network systems. Cancers under investigation will include hepatocellular carcinoma and ovarian follicular cancer. Two of the investigators will continue from the current COBRE (Drs. Singer, Zhitkovich), and 3 are newly hired junior faculty. The proposed research core are Mouse Transgenics, Genomics, and Bioinformatics. The first two carry over from the current Center, while the latter will be established as a new core facility. Each project leader and core director has an assigned senior faculty mentor. The mentors comprise the IAC which is chaired by the PI The EAC evaluates all aspects of the Center's operation and advises the PI and the IAC. The PI is also advised by the Steering Committee of the Brown Center for Genomics and Proteomics, and reports to the Dean of the Medical School and the senior administration. The of the program is to establish both a thematic focus and the caliber of science required for a transition to a PPG funded by the NCI. The following Specific Aims are proposed to achieve these goals: Aim 1: To investigate the role of the gonad-specific transcriptional coactivator TAF4b in the development of ovarian granulosa cell cancer; Aim 2: To examine the function of Wnt signaling networks in the development of hepatocellular carcinoma and to address whether targets in this pathway may be useful for cancer therapy; Aim 3: To describe and functionally test, on a proteome-wide basis, cascades of tyrosine protein phosphorylation triggered by receptor crosslinking in mast cells and by IGF-1 stimulation in hepatocellular carcinoma cells; Aim 4: To elucidate the mechanisms by which Cullin 3 complexes recognize regulatory proteins causally connected to cell cycle aberrations found in cancer and target them for ubiquitin-mediated proteolysis; Aim 5: To discover novel mechanisms by which normal levels of oxidative stress found in all cells participate in generating DNA damage that ultimately leads to the development of cancer.
描述(由申请人提供): 建议建立一个由初级和早期职业教师领导的5个研究项目和3个研究核心设施组成的COBRE。该中心的科学主题将是癌症信号网络,即调节与致癌有关的信号网络的分子机制:转录、蛋白质磷酸化和蛋白质降解。拟议研究的一些重点将是DNA修复,Wnt和IGF-1信号传导,蛋白质磷酸化的蛋白质组范围分析,泛素介导的蛋白质水解,全球RNA聚合酶II机制,致癌的转基因小鼠模型和网络系统的生物信息学推断。正在研究的癌症包括肝细胞癌和卵巢滤泡癌。两名研究人员将继续从目前的COBRE(辛格博士,Zhitkovich),和3名新聘请的初级教师。拟议的研究核心是小鼠转基因,基因组学和生物信息学。前两个中心是从目前的中心转过来的,后一个中心将作为一个新的核心设施。每个项目负责人和核心主任都有一个指定的高级教师导师。顾问委员会负责评估中心运作的各个方面,并向PI和IAC提供建议。PI还由布朗基因组学和蛋白质组学中心指导委员会提供建议,并向医学院院长和高级管理人员报告。该计划的目的是建立一个主题重点和过渡到由NCI资助的PPG所需的科学口径。提出以下具体目的以实现这些目标:目的1:研究性腺特异性转录共激活因子TAF 4 b在卵巢颗粒细胞癌发展中的作用;目的2:检查Wnt信号传导网络在肝细胞癌发展中的功能,并解决该途径中的靶点是否可用于癌症治疗;目的3:在蛋白质组范围内,描述并功能性测试由肥大细胞中的受体交联和肝细胞癌细胞中的IGF-1刺激触发的酪氨酸蛋白磷酸化级联;目的4:为了阐明Cullin 3复合物识别与癌症中发现的细胞周期畸变有因果关系的调节蛋白的机制,目标5:发现所有细胞中正常水平的氧化应激参与产生最终导致癌症发展的DNA损伤的新机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John M Sedivy其他文献

Mysterious liaisons: the relationship between c-Myc and the cell cycle
神秘的联系:c-Myc 与细胞周期之间的关系
  • DOI:
    10.1038/sj.onc.1202749
  • 发表时间:
    1999-05-13
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    Alvaro J Obaya;Maria K Mateyak;John M Sedivy
  • 通讯作者:
    John M Sedivy

John M Sedivy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John M Sedivy', 18)}}的其他基金

Project 1: Activation of Alternative L1 Lifecycles in the CNS with age and Alzheimer's Disease
项目 1:中枢神经系统中 L1 生命周期的激活随着年龄和阿尔茨海默病的增加
  • 批准号:
    10581521
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10333658
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
逆转录转座子活性在神经退行性变和阿尔茨海默氏病中的作用
  • 批准号:
    10333657
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
逆转录转座的体细胞激活:衰老的新分子机制?
  • 批准号:
    9334684
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Somatic Activation of Retrotransposition: A new Molecular Mechanism of Aging?
逆转录转座的体细胞激活:一种新的衰老分子机制?
  • 批准号:
    9522255
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Project 1: Activation of Alternative L1 Lifecycles in the CNS with age and Alzheimer's Disease
项目 1:中枢神经系统中 L1 生命周期的激活随着年龄和阿尔茨海默病的增加
  • 批准号:
    10333661
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
逆转录转座的体细胞激活:衰老的新分子机制?
  • 批准号:
    9755302
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
逆转录转座子活性在神经退行性变和阿尔茨海默氏病中的作用
  • 批准号:
    10581509
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10581510
  • 财政年份:
    2016
  • 资助金额:
    $ 181.33万
  • 项目类别:
2015 Aging, Biology of Gordon Research Conference and Gordon Research Seminar
2015年衰老、生物学戈登研究会议暨戈登研究研讨会
  • 批准号:
    8975254
  • 财政年份:
    2015
  • 资助金额:
    $ 181.33万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 181.33万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 181.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了